Ash Stevens Receives 2014 Lilly Global Supplier Award - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ash Stevens Receives 2014 Lilly Global Supplier Award


Ash Stevens, a provider of global contract pharmaceutical drug substance development and API manufacturing services, received a 2014 Lilly Global Supplier Award.

“We are honored to receive this award and recognition from Eli Lilly and Company. Ash Stevens has a rich history that exceeds 50 years conducting innovative chemical research to develop and manufacture a wide variety of active pharmaceutical ingredients," said Dr. Stephen Munk, president and CEO.

To date, Ash Stevens has received twelve FDA manufacturing approvals for new APIs, including four fast-track manufacturing approvals for the active ingredients in the oncology drugs Velcade, Vidaza, Clolar, and Iclusig.

Source: Ash Stevens

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here